BioMarin’s Voxzogo Expected To Benefit From ‘Sticky’ Nature Of Achondroplasia Market

Sales for the drug grew significantly, with an exec telling the fourth-quarter earnings call that patients with achondroplasia tend to stick with the drugs they are using.